Page 12 - Collaborative Group News Today

This study reports 20-year breast cancer incidence among participants in Women’s Health Initiative (WHI) trials randomized to conjugated equine estrogen (CEE) a

Real-world evidence confirms a kidney benefit for SGLT2i vs DPP4i among patients with type 2 diabetes.

Real-world evidence confirms a kidney benefit for SGLT2i vs DPP4i among patients with type 2 diabetes.

The EMPA-KIDNEY trial showed significant benefit of empagliflozin in reducing kidney disease progression or cardiovascular death in CKD patients.

A city representative said the new policy won't just be about removing washers from public visibility.

Exploring the overlap between HF and COPD and the effect of one condition on the other and addressing the challenges of managing patients with both conditions.

If you are driving around Springfield this fall and notice some new construction, theres a good chance its apartments.

Guanmaitong Granule Attenuates Atherosclerosis by Inhibiting Inflammatory Immune Response in ApoE−/− Mice Fed High-Fat Diet

Nearly three in four patients treated with adjuvant TAGRISSO were alive and disease-free at four years Exploratory results showed TAGRISSO also reduced the risk of disease recurrence in the brain or spinal cord by 76% in patients with Stage II-IIIA disease

Investegate announcements from AstraZeneca PLC, Tagrisso approved in Japan for early lung cancer